Intelligence · Clinical Pipeline
Agios Netherlands Pipeline
All ClinicalTrials.gov programs at Agios Netherlands — phase, modality, and trial IDs.
- Programs
- 45
Quick answer
Agios Netherlands has 45 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
AG-348
Agios Netherlands B.V.
Pyruvate Kinase Deficiency
2 trials -
Mitapivat
Agios Netherlands B.V.
Non-Transfusion-dependent Alpha-Thalassemia
1 trial -
Mitapivat
Agios Netherlands B.V.
Sickle Cell Disease
2 trials -
Mitapivat
Agios Netherlands B.V.
Pediatric Pyruvate Kinase Deficiency
2 trials -
Mitapivat Matched Placebo
Agios Netherlands B.V.
Transfusion-dependent Alpha-Thalassemia
1 trial -
Placebo
Agios Netherlands B.V.
Pyruvate Kinase Deficiency
1 trial -
Placebo Matching Mitapivat
Agios Netherlands B.V.
Non-Transfusion-dependent Alpha-Thalassemia
1 trial -
Placebo Matching Mitapivat
Agios Netherlands B.V.
Transfusion-dependent Alpha-Thalassemia
1 trial -
AG-120
Agios Netherlands B.V.
Chondrosarcoma
1 trial -
AG-348
Agios Netherlands B.V.
Thalassemia
1 trial -
Enasidenib
Agios Netherlands B.V.
Hematologic Neoplasms
1 trial -
Mitapivat
Agios Netherlands B.V.
Anemia
1 trial -
Tebapivat
Agios Netherlands B.V.
Myelodysplastic Syndromes
1 trial -
Tebapivat
Agios Netherlands B.V.
Sickle Cell Disease
1 trial -
ivosidenib and nivolumab
Agios Netherlands B.V.
Advanced Solid Tumor
1 trial -
AG-120 (Ivosidenib)
Agios Netherlands B.V.
Hepatic Impairment
1 trial -
AG-181
Agios Netherlands B.V.
Phenylketonuria
1 trial -
AG-181
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
AG-236
Agios Netherlands B.V.
Healthy Participants
1 trial -
AG-348
Agios Netherlands B.V.
Healthy
1 trial -
AG-348
Agios Netherlands B.V.
Healthy Volunteer
2 trials -
AG-348
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
AG-348
Agios Netherlands B.V.
Sickle Cell Disease
1 trial -
AG-348 Sequence A
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
AG-519
Agios Netherlands B.V.
Anemia
1 trial -
AG-636
Agios Netherlands B.V.
Lymphoma
1 trial -
AG-881
Agios Netherlands B.V.
Healthy Male Participants
1 trial -
AG-881
Agios Netherlands B.V.
Healthy Participants
1 trial -
AG-946
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
AG120
Agios Netherlands B.V.
Healthy
2 trials -
AG221
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
AG881
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
AG881
Agios Netherlands B.V.
Acute Myeloid Leukemia (AML)
1 trial -
AG881 Formulation 1
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
Ivosidenib
Agios Netherlands B.V.
IDH1 Mutation Myeloid Neoplasms
1 trial -
Mitapivat
Agios Netherlands B.V.
Healthy Participants
1 trial -
Mitapivat
Agios Netherlands B.V.
Moderate Hepatic Impairment
1 trial -
Mitapivat tablet
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
Mitapivat tablets
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
Placebo for Treatment A
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
[14C]-AG-120
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
[14C]-tebapivat
Agios Netherlands B.V.
Healthy Participants
1 trial -
itraconazole
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
ivosidenib (AG-120)
Agios Netherlands B.V.
Healthy
1 trial -
Mitapivat
Agios Netherlands B.V.
Pyruvate Kinase Deficiency
2 trials
Frequently asked questions
How many pipeline programs does Agios Netherlands have?
45 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs